Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2002, p. 1132-1135, Vol. 46, No. 4
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.4.1132-1135.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
Received 7 June 2001/ Returned for modification 29 September 2001/ Accepted 13 January 2002
|
|
|---|
|
|
|---|
Seventeen strains of B. pseudomallei isolated from human, animal and environmental sources in Hong Kong and Thailand between 1975 and 1986 were studied. These isolates represent part of a collection that has been described earlier (4, 6, 13). Five human isolates were from Thailand. The remaining 12 isolates were from Hong Kong (5 from humans, 6 from deceased marine mammals, and 1 from soil). All strains were arabinose negative, and none were B. thailendensis.
The MICs of the ß-lactam antibiotics were determined by the Etest (AB Biodisk, Solna, Sweden). ß-Lactamase crude cell extracts were prepared from 100-ml cultures in Luria-Bertani broth (Oxoid, Basingstoke, United Kingdom) by using procedures described previously (6). In brief, cells were killed with toluene and disrupted by sonication. Enzyme yield was increased by a single extraction with Triton X-100 as previously described (6). Cellular debris was removed by centrifugation (30,000 x g), and the supernatant was collected as the source of ß-lactamase. Enzyme extracts were frozen at -70°C until they were tested. Isoelectric focusing of the ß-lactamases was performed with ampholine gel (Pharmacia, Hong Kong, China) from pI 3.5 to pI 9.5. Enzyme extracts from strains expressing TEM-1 (pI 5.4), OXA-1 (pI 7.4), and SHV-1 (pI 7.6) were used as controls. The pI value of each enzyme was determined by overlaying the gel with nitrocefin (12).
Crude lysate without purification was used for substrate and inhibition assays. The assays were performed spectrophotometrically by measuring the change in absorbance at the appropriate wavelength for each substrate by using a Beckman DU650 spectrophotometer (Beckman Coulter, Fullerton, Calif.) (6, 11). Hydrolysis assays were carried out in 0.5 ml of 10 mM phosphate buffer (AMRESCO Inc., Solon, Ohio), pH 7.4, at 37°C. Antibiotic powders with known potencies, including sulbactam (Pfizer Corporation, Hong Kong, China) and clavulanic acid (SmithKline Beecham, Hong Kong, China) were kindly provided by the manufacturers. All other antibiotics were purchased from Sigma (St. Louis, Mo.). The wavelengths were 235 nm for benzylpenicillin and ampicillin, 255 nm for cephaloridine and cephalothin, 257 nm for cefotaxime and ceftazidime, 263 nm for cloxacillin, and 274 nm for cefuroxime. Vmax and Km were calculated by the Lineweaver-Burk plot using the built-in Enzymatic Mechanism software (3). All kinetic studies were performed three times.
Cloning and sequence analysis of the ß-lactamase gene from a B. pseudomallei strain (HK-PPM-1, a strain isolated from a dolphin in 1975) was performed as follows (9). A set of primers was used to amplify the ß-lactamase gene from the genomic DNA. Primers were designed by a BLAST analysis of the B. pseudomallei genome sequence at the Sanger Center with ß-lactamase gene penA from B. cepacia. The oligonucleotide primers used were forward primer F1 (5'-CCG GAA TTC ATG AAT CAT TCT CCG TTG CGC CGC TCG C-3'; nucleotide positions 1 to 28) and backward primer B1 (5'-GCT CTA GAT CAG GCG AAC GCC CGC GCG GCG ATC CGC-3'; nucleotide positions 888 to 861). Restriction sites (underlined) were incorporated into the primers (an EcoRI restriction site for the forward primer and an XbaI restriction site for the backward primer) for ligation of the amplified products to phagemid vector pBK-CMV (Kanr; Stratagene, La Jolla, Calif.). Afterward, CaCl2-treated Escherichia coli XL1-Blue MRF' (ampicillin sensitive) was transformed with the recombinant plasmid (12) and clones were selected on Luria-Bertani agar supplemented with ampicillin (25 µg/ml) and kanamycin (50 µg/ml). The 0.9-kb DNA insert into the recombinant plasmids (pBKCMV01 and pBKCMV07) of two ampicillin-kanamycin-resistant clones (E. coli XL1-Blue MRF' P1 and P7) was confirmed by sequencing using the T3 and T7 vector sequence as the primers. Bidirectional sequencing of both strands was performed by the Bigdye dideoxynucleotide chain termination method with an ABI PRISM 310 Genetic Analyzer (Perkin-Elmer Corp., Foster City, Calif.). Subsequently, the ß-lactamase-encoding genes in all of the strains were amplified and sequenced by using primers with the sequences 5'-ATC CGC CTG ATG AAT CAT TC-3' (F2 forward, positions -9 to 11) and 5'-GCG CGC TCA GGC GAA CGC CC-3' (B2 backward, positions 894 to 875). Around 600 to 650 bases of both strands were sequenced in each direction. Both strands of the ß-lactamase-encoding genes in PPM-1, P1, and P7 were sequenced twice. Both strands of the ß-lactamase gene variants were also sequenced twice. The ß-lactamase sequences in the remaining strains were sequenced once.
Isoelectric focusing analysis of the parental strain (HK-PPM-1) and the two E. coli clones (P1 and P7) revealed only a single ß-lactamase with the same isoelectric point of 7.7. The ß-lactam susceptibility profiles of the parental B. pseudomallei strain (HK-PPM-1), the reference strain (E. coli XL1-Blue MRF'), and E. coli strains P1 and P7 are shown in Table 1. The kinetic parameters of the ß-lactamase enzyme with a pI of 7.7 obtained from the B. pseudomallei parental strain and E. coli clone P1 are shown in Table 2.
|
View this table: [in a new window] |
TABLE 1. MICs of ß-lactams for reference and ß-lactamase (BPS-1)-producing strains
|
|
View this table: [in a new window] |
TABLE 2. Kinetic parameters of BPS-1 ß-lactamase
|
Met at position 139 (1 strain, BPS-1b), Pro
Leu at position 145 (1 strain, BPS-1c), and Ala
Thr at position 147 (10 strains, BPS-1d). These substitutions had no correlation with the geographic source and host origin of the isolates.
![]() View larger version (61K): [in a new window] |
FIG. 1. Sequence alignment of the BPS-1 ß-lactamase from B. pseudomallei with its nearest class A neighbors. Identical residues are in boldface. Colons were introduced to adjust the alignment. The start of the putative mature protein is underlined. The conserved motifs (70SXXK73, 130SDN132, 166EXXXN170, and 234KTG236) typical of class A ß-lactamases are shaded. Arrows indicate the putative omega loop region (7). The ABL consensus sequence is shown for comparison (1). The sources (GenBank accession numbers) of the ß-lactamases are as follows: BPS-1, B. pseudomallei (AF326770); PenA, B. cepacia (AAB53622); BlaI, Y. enterocolitica (CAA40357); CTX-M-13, K. pneumoniae (AAK55533); SFO-1, E. cloacae (BAA76882); FONA-4, S. fonticola (CAB61641); OXY-1a, K. oxytoca (CAB42615).
|
In terms of sequence homology, several lineages of class A ß-lactamases can be distinguished (7). In this regard, BPS-1 is phylogenetically nearest to PenA of B. cepacia (14) and BlaI of Y. enterocolitica (10). A feature common to the three enzymes is that they are chromosomally encoded. Interestingly, BPS-1 is a cephalosporinase while the latter two are penicillinases. Despite these differences, the efficiencies of hydrolysis (Vmax/Km relative to that of ampicillin) of BPS-1 and PenA (5) for cefuroxime (176 and 188, respectively) and cefotaxime (60 and 57, respectively) are remarkably similar. Like BPS-1, BlaI of Y. enterocolitica is also a group 2e cefuroxime-hydrolyzing enzyme similar to the inducible cephalosporinases from P. vulgaris (2). Furthermore, BPS-1 also behaves like the related family of CTX-M ß-lactamases that are endemic to Latin America and some areas of northeastern Europe (15). Like BPS-1, these enzymes hydrolyze cefotaxime but exhibit little activity against ceftazidime. Characteristically, enzymatic activities are inhibited by low concentrations of clavulanic acid and sulbactam. Unlike BPS-1, the CTX-M enzymes are encoded on plasmids.
In summary, the sequences of the class A enzyme BPS-1 in B. pseudomallei and other, related ß-lactamases were compared. The sequences of the wild-type enzymes from human, animal, and soil isolates appeared to be quite homogeneous.
Nucleotide sequence accession numbers. The sequences of the blaABPS-1 genes have been given GenBank accession numbers AF326770 and AF441237 to -39.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»